Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $41.9000 (-0.24%) ($41.4500 - $43.5500) on Thu. Mar. 15, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.66% (three month average) | RSI | 47 | Latest Price | $41.9000(-0.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -3.33% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-10%) UNG(-5%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.33% (StdDev 6.66%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $42.79 | 5 Day Moving Average | $43.07(-2.72%) | 10 Day Moving Average | $42.76(-2.01%) | 20 Day Moving Average | $42.79(-2.08%) | To recent high | -13.3% | To recent low | 188% | Market Cap | $3.114b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |